263
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association Between Elevated Blood Eosinophils and Chronic Kidney Disease Progression: Analyses of a Large United States Electronic Health Records Database

, , ORCID Icon, , , , , , & show all
Pages 269-280 | Received 08 Sep 2023, Accepted 09 Dec 2023, Published online: 20 Dec 2023

References

  • Ramirez GA, Yacoub M-R, Ripa M, et al. Eosinophils from physiology to disease: a comprehensive review. Biomed Res Int 2018;2018:1–28. doi:10.1155/2018/9095275
  • Niccoli G, Ferrante G, Cosentino N, et al. Eosinophil cationic protein: a new biomarker of coronary atherosclerosis. Atherosclerosis. 2010;211(2):606–611. doi:10.1016/j.atherosclerosis.2010.02.038
  • Lacy P, Moqbel R. Immune effector functions of eosinophils in allergic airway inflammation. Curr Opin Allergy Clin Immunol. 2001;1(1):79–84. doi:10.1097/00130832-200102000-00014
  • Furuta GT, Atkins FD, Lee NA, et al. Changing roles of eosinophils in health and disease. Ann Allergy Asthma Immunol. 2014;113(1):3–8. doi:10.1016/j.anai.2014.04.002
  • Di Stefano F, Amoroso A. Clinical approach to the patient with blood eosinophilia. Eur Ann Allergy Clin Immunol. 2005;37(10):380–386.
  • Liao W, Long H, Chang CC, et al. The eosinophil in health and disease: from bench to bedside and back. Clin Rev Allergy Immunol. 2016;50(2):125–139. doi:10.1007/s12016-015-8507-6
  • Jacobsen EA, Jackson DJ, Heffler E, et al. Eosinophil knockout humans: uncovering the role of eosinophils through eosinophil-directed biological therapies. Annu Rev Immunol. 2021;39(1):719–757. doi:10.1146/annurev-immunol-093019-125918
  • Akuthota P, Weller PF. Spectrum of eosinophilic end-organ manifestations. Immunol Allergy Clin North Am. 2015;35(3):403–411. doi:10.1016/j.iac.2015.04.002
  • Hou L, Lloyd-Jones DM, Ning H, et al. White blood cell count in young adulthood and coronary artery calcification in early middle age: coronary artery risk development in young adults (cardia) study. Eur J Epidemiol. 2013;28(9):735–742. doi:10.1007/s10654-013-9842-7
  • Zhao X, Jiang L, Xu L, et al. Predictive value of in-hospital white blood cell count in Chinese patients with triple-vessel coronary disease. Eur J Prev Cardiol. 2019;26(8):872–882. doi:10.1177/2047487319826398
  • Dembic M, Hedley PL, Torp-Pedersen C, et al. Pregnancy-associated plasma protein-A (papp-A) and the proform of the eosinophil major basic protein (prombp) are associated with increased risk of death in heart failure patients. Scand J Clin Lab Invest. 2017;77(5):352–357. doi:10.1080/00365513.2017.1325926
  • Tariq A, Okamato K, Tariq A, et al. Eosinophilia and risk of incident end stage kidney disease. BMC Nephrol. 2020;21(1):14. doi:10.1186/s12882-020-1685-3
  • Ishii R, Fujita S, Kizawa S, et al. Association between absolute blood eosinophil count and CKD stages among cardiac patients. Heart Vessels. 2016;31(2):198–205. doi:10.1007/s00380-014-0590-8
  • Agarwal R, Light RP. Patterns and prognostic value of total and differential leukocyte count in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(6):1393–1399. doi:10.2215/CJN.10521110
  • Yilmaz I, Turk M. What should be the cutoff value of blood eosinophilia as a predictor of inhaled corticosteroid responsiveness in patients with chronic obstructive pulmonary disease? Am J Respir Crit Care Med. 2017;196(9):1229–1230. doi:10.1164/rccm.201705-0892LE
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8
  • Kuang FL. Approach to patients with eosinophilia. Med Clin North Am. 2020;104(1):1–14. doi:10.1016/j.mcna.2019.08.005
  • Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease - A systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765. doi:10.1371/journal.pone.0158765
  • Romagnani P, Remuzzi G, Glassock R, et al. Chronic kidney disease. Nat Rev Dis Primers. 2017;3:17088. doi:10.1038/nrdp.2017.88
  • Mallappallil M, Friedman EA, Delano BG, et al. Chronic kidney disease in the elderly: evaluation and management. Clin Pract. 2014;11(5):525–535. doi:10.2217/cpr.14.46
  • Tsai WC, Wu HY, Peng YS, et al. Risk factors for development and progression of chronic kidney disease: a systematic review and exploratory meta-analysis. Medicine. 2016;95(11):e3013. doi:10.1097/MD.0000000000003013
  • Hounkpatin HO, Fraser SDS, Honney R, et al. Ethnic minority disparities in progression and mortality of pre-dialysis chronic kidney disease: a systematic scoping review. BMC Nephrol. 2020;21(1):217. doi:10.1186/s12882-020-01852-3
  • McClellan WM, Flanders WD. Risk factors for progressive chronic kidney disease. J Am Soc Nephrol. 2003;14(7 Suppl 2):S65–S70. doi:10.1097/01.ASN.0000070147.10399.9E
  • Gauckler P, Shin JI, Mayer G, et al. Eosinophilia and kidney disease: more than just an incidental finding? J Clin Med. 2018;7(12):529. doi:10.3390/jcm7120529
  • Nagata M, Nakagome K, Soma T. Mechanisms of eosinophilic inflammation. Asia Pac Allergy. 2020;10(2):e14. doi:10.5415/apallergy.2020.10.e14
  • Mihai S, Codrici E, Popescu ID, et al. Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome. J Immunol Res. 2018;2018:2180373. doi:10.1155/2018/2180373